Medicare Enrolled
Dr. Salah Fares, MD
Pulmonary Disease · Southfield, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fares from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fares?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fares
Dr. Salah Fares is a pulmonary disease specialist in Southfield, MI, with 18 years of NPI registration. Based on federal Medicare data, Dr. Fares performed 7,092 Medicare services across 2,479 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fares received a total of $4,057 from 32 pharmaceutical and/or device companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fares is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in MI
$4,057 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,092
Medicare services
Top 1% in MI for pulmonary disease
2,479
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~394 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,800 | $0 | $0 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
1,536 | $3 | $11 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
944 | $93 | $269 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
597 | $91 | $264 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
311 | $129 | $524 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
236 | $62 | $188 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
215 | $29 | $157 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
215 | $42 | $142 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
215 | $43 | $141 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
196 | $11 | $53 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
178 | $65 | $336 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
136 | $132 | $356 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
100 | $17 | $52 |
| New patient office visit, complex (60-74 min) | 93 | $153 | $508 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
56 | $26 | $89 |
| Allergy injection therapy, multiple injections A professional service involving the administration of multiple allergen injections. |
37 | $8 | $31 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
34 | $20 | $71 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
32 | $14 | $37 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $67 | $178 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
27 | $167 | $707 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
20 | $25 | $659 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
19 | $479 | $1,301 |
| CT scan of chest blood vessels with contrast A CT scan that uses contrast dye to create detailed images of the blood vessels in the chest. |
15 | $139 | $664 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
14 | $499 | $1,369 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $121 | $422 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
12 | $79 | $672 |
| Low dose CT scan of chest for lung cancer screening A specialized CT scan of the chest using a lower radiation dose to screen for lung cancer. |
12 | $95 | $286 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,057
Total received (2018-2024)
Avg $580/year across 7 years
Top 27% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
134
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,539 (62.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,518 (37.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,064
2023
$768
2022
$220
2021
$5
2020
$232
2019
$380
2018
$387
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$1,500
Electromed, Inc.
$265
GENZYME CORPORATION
$51
Inspire Medical Systems, Inc.
$51
Boston Scientific Corporation
$43
Takeda Pharmaceuticals U.S.A., Inc.
$38
Insmed, Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Regeneron Healthcare Solutions, Inc.
$18
AstraZeneca Pharmaceuticals LP
$18
Pulmonx Corporation
$17
Gilead Sciences, Inc.
$14
Top 3 companies account for 88.0% of 2024 payments
All-time payments by company (2018-2024) ›
INTUITIVE SURGICAL, INC.
$1,500
Electromed, Inc.
$521
GlaxoSmithKline, LLC.
$336
Boehringer Ingelheim Pharmaceuticals, Inc.
$211
Genentech USA, Inc.
$162
Pulmonx Corporation
$139
GENZYME CORPORATION
$129
Philips Electronics North America Corporation
$122
Respicardia, Inc.
$119
AstraZeneca Pharmaceuticals LP
$93
Inspire Medical Systems, Inc.
$77
Sunovion Pharmaceuticals Inc.
$71
Novartis Pharmaceuticals Corporation
$53
Mylan Specialty L.P.
$52
Regeneron Healthcare Solutions, Inc.
$51
Boston Scientific Corporation
$43
PFIZER INC.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$38
Intuitive Surgical, Inc.
$34
Gilead Sciences, Inc.
$32
Harmony Biosciences LLC
$29
Insmed, Inc.
$24
Allergan, Inc.
$24
United Therapeutics Corporation
$24
Abbott Laboratories
$21
Actelion Pharmaceuticals US, Inc.
$21
Optinose US, Inc.
$18
Circassia Pharmaceuticals Inc
$16
Shire North American Group Inc
$16
Allergan Inc.
$14
Merck Sharp & Dohme Corporation
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
Top 3 companies account for 58.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ARALAST · AREXVY · AVYCAZ · Adempas · Arikayce · BREZTRI · BROVANA · CARDIOMEMS · CHARTIS CATHETER · DUPIXENT · Da Vinci Surgical System · ELIQUIS · Esbriet · FASENRA · GLASSIA · INSPIRE · LONHALA MAGNAIR · NUCALA · OFEV · ORENITRAM · Pulmonx Endobronchial Valve EBV · Respiratoriy Care Undiv · SMARTVEST · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TheraSphere Y90 Glass Microspheres 10 GBq · Trilogy 100 · UPTRAVI · Utibron · Veklury · WAKIX · Wellcentive Undiv · XOLAIR · Xhance · Xolair · Yupelri · ZERBAXA · inCourage · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (63%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
113
Per 100K population
8.9
County median income
$95,296
Nearest hospital
STRAITH HOSPITAL FOR SPECIAL SURGERY
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fares is a mixed practice specialist, with above-average Medicare volume (top 1% in MI), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fares experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Fares performed 1,800 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fares receive payments from pharmaceutical companies?
Yes. Dr. Fares received a total of $4,057 from 32 companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fares's costs compare to other pulmonary diseases in Southfield?
Dr. Fares's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fares) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Southfield
Browse pulmonary diseases in Southfield ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in MI
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in MI
Which MI pulmonary diseases receive the most from drug and device companies.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
Electromed, Inc. Payments to Doctors
See all physicians who received payments from Electromed, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology